170 related articles for article (PubMed ID: 25171000)
1. Successful construction and massive expression of a novel Anti-CD19 human-mouse chimeric antibody Hm2E8b.
Shen D; Tang Y; Li S; Xu W; Zhang L
Monoclon Antib Immunodiagn Immunother; 2014 Aug; 33(4):215-20. PubMed ID: 25171000
[TBL] [Abstract][Full Text] [Related]
2. A tetravalent bispecific TandAb (CD19/CD3), AFM11, efficiently recruits T cells for the potent lysis of CD19(+) tumor cells.
Reusch U; Duell J; Ellwanger K; Herbrecht C; Knackmuss SH; Fucek I; Eser M; McAleese F; Molkenthin V; Gall FL; Topp M; Little M; Zhukovsky EA
MAbs; 2015; 7(3):584-604. PubMed ID: 25875246
[TBL] [Abstract][Full Text] [Related]
3. A recombinant triplebody with specificity for CD19 and HLA-DR mediates preferential binding to antigen double-positive cells by dual-targeting.
Schubert I; Kellner C; Stein C; Kügler M; Schwenkert M; Saul D; Stockmeyer B; Berens C; Oduncu FS; Mackensen A; Fey GH
MAbs; 2012; 4(1):45-56. PubMed ID: 22327429
[TBL] [Abstract][Full Text] [Related]
4. Generation and characterization of a single-gene mouse-human chimeric antibody against hepatitis B surface antigen.
Bose B; Khanna N; Acharya SK; Sinha S
J Gastroenterol Hepatol; 2006 Sep; 21(9):1439-47. PubMed ID: 16911690
[TBL] [Abstract][Full Text] [Related]
5. Generation and characterization of chimeric antibodies against NS3, NS4, NS5, and core antigens of hepatitis C virus.
Tu B; Ziemann RN; Tieman BC; Hawksworth DJ; Tyner J; Scheffel J; Pinkus MS; Brophy SE; Werneke JM; Gutierrez R; White M
Clin Vaccine Immunol; 2010 Jun; 17(6):1040-7. PubMed ID: 20427624
[TBL] [Abstract][Full Text] [Related]
6. Preparation of human IgG and IgM monoclonal antibodies for MK-1/Ep-CAM by using human immunoglobulin gene-transferred mouse and gene cloning of their variable regions.
Kuroki M; Yamada H; Shibaguchi H; Hachimine K; Hirose Y; Kinugasa T; Ishida I; Kuroki M
Anticancer Res; 2005; 25(6A):3733-9. PubMed ID: 16302733
[TBL] [Abstract][Full Text] [Related]
7. A CD19/Fc fusion protein for detection of anti-CD19 chimeric antigen receptors.
De Oliveira SN; Wang J; Ryan C; Morrison SL; Kohn DB; Hollis RP
J Transl Med; 2013 Jan; 11():23. PubMed ID: 23360526
[TBL] [Abstract][Full Text] [Related]
8. [Stable expression of human anti-IL-33 scFv-IgG1Fc fusion protein in CHO k1 cells].
Ye Y; Nian S; Wang X; Wu T; Xu W; Yuan Q
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 May; 32(5):600-3, 608. PubMed ID: 27126936
[TBL] [Abstract][Full Text] [Related]
9. Retargeting CD19 Chimeric Antigen Receptor T Cells via Engineered CD19-Fusion Proteins.
Klesmith JR; Su L; Wu L; Schrack IA; Dufort FJ; Birt A; Ambrose C; Hackel BJ; Lobb RR; Rennert PD
Mol Pharm; 2019 Aug; 16(8):3544-3558. PubMed ID: 31242389
[TBL] [Abstract][Full Text] [Related]
10. Chimeric anti-ganglioside GM2 antibody with antitumor activity.
Nakamura K; Koike M; Shitara K; Kuwana Y; Kiuragi K; Igarashi S; Hasegawa M; Hanai N
Cancer Res; 1994 Mar; 54(6):1511-6. PubMed ID: 8137257
[TBL] [Abstract][Full Text] [Related]
11. A single-chain triplebody with specificity for CD19 and CD33 mediates effective lysis of mixed lineage leukemia cells by dual targeting.
Schubert I; Kellner C; Stein C; Kügler M; Schwenkert M; Saul D; Mentz K; Singer H; Stockmeyer B; Hillen W; Mackensen A; Fey GH
MAbs; 2011; 3(1):21-30. PubMed ID: 21081841
[TBL] [Abstract][Full Text] [Related]
12. Construction, Expression, and Characterization of a Novel Human-Mouse Chimeric Antibody, Hm3A4: A Potential Therapeutic Agent for B and Myeloid Lineage Leukemias.
Li S; Shen D; Guo X; Liao C; Tang Y
DNA Cell Biol; 2018 Sep; 37(9):778-785. PubMed ID: 30096000
[TBL] [Abstract][Full Text] [Related]
13. Production and characterization of a set of mouse-human chimeric immunoglobulin G (IgG) subclass and IgA monoclonal antibodies with identical variable regions specific for Pseudomonas aeruginosa serogroup O6 lipopolysaccharide.
Preston MJ; Gerçeker AA; Reff ME; Pier GB
Infect Immun; 1998 Sep; 66(9):4137-42. PubMed ID: 9712759
[TBL] [Abstract][Full Text] [Related]
14. Construction and expression of a novel anti-CD14 human-mouse chimeric antibody Hm2F9.
Shen DY; Ning BT; Tang YM; Li SS
DNA Cell Biol; 2014 Sep; 33(9):599-604. PubMed ID: 24905979
[TBL] [Abstract][Full Text] [Related]
15. Combined Fc-protein- and Fc-glyco-engineering of scFv-Fc fusion proteins synergistically enhances CD16a binding but does not further enhance NK-cell mediated ADCC.
Repp R; Kellner C; Muskulus A; Staudinger M; Nodehi SM; Glorius P; Akramiene D; Dechant M; Fey GH; van Berkel PH; van de Winkel JG; Parren PW; Valerius T; Gramatzki M; Peipp M
J Immunol Methods; 2011 Oct; 373(1-2):67-78. PubMed ID: 21855548
[TBL] [Abstract][Full Text] [Related]
16. Fc engineering: design, expression, and functional characterization of antibody variants with improved effector function.
Derer S; Kellner C; Berger S; Valerius T; Peipp M
Methods Mol Biol; 2012; 907():519-36. PubMed ID: 22907372
[TBL] [Abstract][Full Text] [Related]
17. Construction, purification, and characterization of anti-BAFF scFv-Fc fusion antibody expressed in CHO/dhfr- cells.
Cao M; Cao P; Yan H; Lu W; Ren F; Hu Y; Zhang S
Appl Biochem Biotechnol; 2009 Jun; 157(3):562-74. PubMed ID: 19099209
[TBL] [Abstract][Full Text] [Related]
18. Construction and expression of anti-Tn-antigen-specific single-chain antibody genes from hybridoma producing MLS128 monoclonal antibody.
Yuasa N; Ogawa H; Koizumi T; Tsukamoto K; Matsumoto-Takasaki A; Asanuma H; Nakada H; Fujita-Yamaguchi Y
J Biochem; 2012 Apr; 151(4):371-81. PubMed ID: 22318767
[TBL] [Abstract][Full Text] [Related]
19. Horse cytokine/IgG fusion proteins--mammalian expression of biologically active cytokines and a system to verify antibody specificity to equine cytokines.
Wagner B; Robeson J; McCracken M; Wattrang E; Antczak DF
Vet Immunol Immunopathol; 2005 May; 105(1-2):1-14. PubMed ID: 15797470
[TBL] [Abstract][Full Text] [Related]
20. Manipulating mIgD-expressing B cells with anti-migis-δ monoclonal antibodies.
Chen NY; Hung AF; Lin CJ; Chen JB; Chu HM; Yu HM; Chang HY; Chang TW
Mol Immunol; 2013 Mar; 53(3):187-97. PubMed ID: 22944457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
